May 28 |
Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention
|
May 22 |
Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
|
May 21 |
Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia
|
May 15 |
Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
|
May 13 |
Tonix Pharmaceuticals GAAP EPS of -$0.18 beats by $0.16, revenue of $2.48M misses by $1.39M
|
May 13 |
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
|
Apr 29 |
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
|
Apr 29 |
TNXP: Approval of First New Fibromyalgia Drug in 15 Years Possible in 2025…
|
Apr 24 |
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
|
Apr 9 |
3 Biotech Stocks to Dump Before They Go to Zero
|